(Q35102398)

6 August 2017

title

Effect of calcium carbonate on bioavailability of orally administered gemifloxacin (English)

1 reference

6 August 2017

0 references

M W Pletz

1

1 reference

6 August 2017

P Petzold

2

1 reference

6 August 2017

A Allen

3

1 reference

6 August 2017

O Burkhardt

4

1 reference

6 August 2017

H Lode

5

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

47

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

2158-2160

1 reference

A critical review of the fluoroquinolones: focus on respiratory infections

6 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=161830

Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=161830

Absorption interactions with fluoroquinolones. 1995 update

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=161830

Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=161830

Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance.

9 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=161830

Evaluation of in vitro susceptibility testing criteria for gemifloxacin when tested against Haemophilus influenzae strains with reduced susceptibility to ciprofloxacin and ofloxacin

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=161830

10.1128/AAC.47.7.2158-2160.2003

27 September 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference